Lead Discovery Center GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lead Discovery Center GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10623
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lead Discovery Center GmbH (LDC), a subsidiary of Max Planck Innovation GmbH is a biomedical research company that offers development of novel drugs and therapies. The company develops drugs and therapies for diseases such as neurodegenerative cardiovascular diseases, cancer, inflammatory disorders, inflammatory disorders and infections, metabolic syndrome, and unmet clinical needs. It offers services such as medical chemistry through organic synthesis, design of focused compound libraries, establishment of structure-activity, computer-aided rational drug design, and structure-property relationships, among others. LDC offers services through its departments including assay development and screening, medicinal chemistry, biology and pharmacology. The company collaborates with universities and academic research institutions for professional drug discovery support. LDC is headquartered in Dortmund, Germany.

Lead Discovery Center GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
UGISense Raises Funds through Financing 12
UGISense to Raise USD1.3 Million Venture Financing 13
Partnerships 14
APEIRON Biologics Enters into Agreement with Lead Discovery Center 14
Grunenthal, Lead Discovery Center, Max-Planck Innovation and Max Planck Institute of Experimental Medicine Enter into Agreement 15
Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Enter into Research Agreement 16
Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 17
Lead Discovery Center to Enter into Development Agreement with UGISense 18
Lead Discovery Center Enters into Research Agreement with McGill University 19
LDC, Max Planck Innovation Enters into Agreement with Boehringer Ingelheim 20
Lead Discovery Center to Enter into Drug Discovery Agreement with Roche 21
Lead Discovery Center Partners with Infinity Pharma 22
Johnson & Johnson Innovation Partners with Lead Discovery Center 23
Qurient Enters into Agreement with Lead Discovery Center 24
AstraZeneca Expands Drug Discovery Agreement with Lead Discovery Center 25
Lead Discovery Center Enters into Research Agreement with Helmholtz Center 26
Lead Discovery Center Enters into Agreement with UiT The Arctic University of Norway 27
Lead Discovery Center Partners with Helmholtz Association of German Research Centres 28
Daiichi Sankyo Enters Into Drug Discovery Agreement With Lead Discovery Center 29
Lead Discovery Center, Centre for Drug Design and Discovery and Axxam Form Joint Venture 30
Merck Serono Enters Into Discovery Agreement With Lead Discovery Center 31
AstraZeneca Enters Into Drug Discovery Agreement With Lead Discovery Center 32
Licensing Agreements 33
Sotio Enters into Licensing Agreement with Lead Discovery Center 33
Lead Discovery Center Enters into Licensing Agreement with Qurient 34
Qurient Enters Into Licensing Agreement with Max Planck Society and Lead Discovery Center 35
Max Planck Institute of Biochemistry And Lead Discovery Center Enter Into Licensing Agreement With Qurient For Kinase Inhibitor 36
Lead Discovery Center GmbH – Key Competitors 38
Lead Discovery Center GmbH – Key Employees 39
Lead Discovery Center GmbH – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Joint Venture 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lead Discovery Center GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
UGISense Raises Funds through Financing 12
UGISense to Raise USD1.3 Million Venture Financing 13
APEIRON Biologics Enters into Agreement with Lead Discovery Center 14
Grunenthal, Lead Discovery Center, Max-Planck Innovation and Max Planck Institute of Experimental Medicine Enter into Agreement 15
Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Enter into Research Agreement 16
Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 17
Lead Discovery Center to Enter into Development Agreement with UGISense 18
Lead Discovery Center Enters into Research Agreement with McGill University 19
LDC, Max Planck Innovation Enters into Agreement with Boehringer Ingelheim 20
Lead Discovery Center to Enter into Drug Discovery Agreement with Roche 21
Lead Discovery Center Partners with Infinity Pharma 22
Johnson & Johnson Innovation Partners with Lead Discovery Center 23
Qurient Enters into Agreement with Lead Discovery Center 24
AstraZeneca Expands Drug Discovery Agreement with Lead Discovery Center 25
Lead Discovery Center Enters into Research Agreement with Helmholtz Center 26
Lead Discovery Center Enters into Agreement with UiT The Arctic University of Norway 27
Lead Discovery Center Partners with Helmholtz Association of German Research Centres 28
Daiichi Sankyo Enters Into Drug Discovery Agreement With Lead Discovery Center 29
Lead Discovery Center, Centre for Drug Design and Discovery and Axxam Form Joint Venture 30
Merck Serono Enters Into Discovery Agreement With Lead Discovery Center 31
AstraZeneca Enters Into Drug Discovery Agreement With Lead Discovery Center 32
Sotio Enters into Licensing Agreement with Lead Discovery Center 33
Lead Discovery Center Enters into Licensing Agreement with Qurient 34
Qurient Enters Into Licensing Agreement with Max Planck Society and Lead Discovery Center 35
Max Planck Institute of Biochemistry And Lead Discovery Center Enter Into Licensing Agreement With Qurient For Kinase Inhibitor 36
Lead Discovery Center GmbH, Key Competitors 38
Lead Discovery Center GmbH, Key Employees 39
Lead Discovery Center GmbH, Subsidiaries 40
Lead Discovery Center GmbH, Joint Venture 40

List of Figures
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Lead Discovery Center GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stanwell Corporation Ltd:企業の戦略的SWOT分析
    Stanwell Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Curevac AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Curevac AG (Curevac), formerly CureVac GmbH is a clinical-stage biopharmaceutical company that develops RNA-based medicines. The company develops, designs, and produces messenger RNA molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its RN …
  • Qinetiq Group Plc:企業の戦略・SWOT・財務分析
    Qinetiq Group Plc - Strategy, SWOT and Corporate Finance Report Summary Qinetiq Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hokuriku Electric Power Co (9505):企業の財務・戦略的SWOT分析
    Hokuriku Electric Power Co (9505) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • DSE, Inc.:企業の戦略・SWOT・財務情報
    DSE, Inc. - Strategy, SWOT and Corporate Finance Report Summary DSE, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Largan Precision Co Ltd (3008):企業の財務・戦略的SWOT分析
    Largan Precision Co Ltd (3008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Oncternal Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Oncternal Therapeutics Inc (Oncternal), formerly Tokalas, Inc., is a clinical-stage oncology company which focuses on the development of therapies for rare and common cancers. Its pipeline compound portfolio includes cirmtuzumab and TK216. The company’s pipeline compounds are primarily focus …
  • Valneva SE:企業のM&A・事業提携・投資動向
    Valneva SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Valneva SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Per Aarsleff Holding AS (PAAL B):企業の財務・戦略的SWOT分析
    Per Aarsleff Holding AS (PAAL B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • DNB ASA:企業の戦略・SWOT・財務情報
    DNB ASA - Strategy, SWOT and Corporate Finance Report Summary DNB ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • DHL Parcel UK Ltd:企業の戦略的SWOT分析
    DHL Parcel UK Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Bank of Baroda:企業のM&A・事業提携・投資動向
    Bank of Baroda - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of Baroda Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Orange and Rockland Utilities, Inc.:企業の戦略的SWOT分析
    Orange and Rockland Utilities, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • SM Energy Company:企業のM&A・事業提携・投資動向
    SM Energy Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SM Energy Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Nippon Chemiphar Co Ltd (4539):企業の財務・戦略的SWOT分析
    Summary Nippon Chemiphar Co Ltd (Nippon Chemiphar) is a provider of pharmaceutical drugs and health-related services. The company manufactures, supplies, imports and exports ethical pharmaceuticals and diagnostic agents. It offers diagnostic products, such as IgE NC, a diagnostic kit that provides r …
  • Maersk Tankers AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Maersk Tankers AS (Maersk Tankers), a subsidiary of A.P. Moeller Holding AS is an oil and gas company that offers energy transportation services through oil tankers. The company provides services such as crude oil and refined oil transportation, warehousing and distribution, supply chain man …
  • Schindler Holding Ltd.:企業の戦略・SWOT・財務情報
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Invenergy LLC:発電所・企業SWOT分析
    Invenergy LLC - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Irkut Corporation (IRKT):企業の財務・戦略的SWOT分析
    Irkut Corporation (IRKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PDL BioPharma Inc:企業の戦略的SWOT分析
    PDL BioPharma Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆